跳至主要内容
临床试验/NCT01905748
NCT01905748Unknown不适用

Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine, Laboratory Investigations in Steady State and During Migraine Attack

HaEmek Medical Center, Israel2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2011年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
15
试验地点
2
主要终点
Proportion of patients with activation of the coagulation system.

研究概览

简要总结

Acute Migraine attacks can be related to vascular or coagulation activation. Previous studies found relative high incidence of prothrombotic events in Migraine. The present study intends to assess the coagulation system and activation in patients with Migraine during steady state phase and at the beginning of attacks and after 72 hours. A control group of patients with another acute neurologic event like convulsions will be also studied. Patients will be at pediatric age and teenagers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
5 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients at the pediatric age (5 to 20 ys old) suffering from Migraine attacks diagnosed by a neurologist.

排除标准

  • Patients with other underlying neurological conditions of coagulation diseases

研究组 & 干预措施

Patients during Migraine attacks

Experimental

Patients with Migraine before, during and after Migraine attacks. Acute phase reaction profile, and activation of the coagulation system will be investigated together with thrombophilia profile.

干预措施: Laboratory tests (Other)

Control group

Experimental

Patients with acute neurologic events like convulsions not related to fever or central nervous system (CNS) infections will be studied including acute phase reaction laboratory tests, thrombophilia and activation of the coagulation system

干预措施: Laboratory tests (Other)

结局指标

主要结局

Proportion of patients with activation of the coagulation system.

时间窗: Two years, each patient will be studied at attack onset and after 72 hours.

The further analysis will be performed in each patient: Pt, PTT, Platelets, Protein C, S, Antithrombin III, D Dimer, Factor VIII, Factor IX, Von Willebrand Factor and Prothrombin fragments I and II will be analyzed on day one of the crises, after 72 hours and in steady state.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Koren Ariel

Head of Pediatric Dpt B and Pediatric Hematology Unit

HaEmek Medical Center, Israel

研究点 (2)

Loading locations...

相似试验